Parkinson’s Disease Associated with GBA G... - Cure Parkinson's

Cure Parkinson's

25,803 members27,102 posts

Parkinson’s Disease Associated with GBA Gene Mutations: Molecular Aspects and Potential Treatment Approaches

pmmargo profile image
3 Replies

When President Putin came down with PD I predicted the Russian scientists would make great progress on our disease. They are not disappointing me. Here they connect a bunch of mutations with their phenotypes. I was especially pleased to learn my mutation is favorable and ambroxyl holds promise.

ncbi.nlm.nih.gov/pmc/articl...

Written by
pmmargo profile image
pmmargo
To view profiles and participate in discussions please or .
3 Replies
park_bear profile image
park_bear

Thanks for posting a link to real research rather than a news article or PR.

Regarding Putin that appears to be unconfirmed rumor.

Getz profile image
Getz

Its just a pity the report is written in scientific language which I cannot understand. Is there something we can take or do that will improve our symptoms?

pmmargo profile image
pmmargo in reply to Getz

I think it is smart to see if you can be tested (your DNA) to find out if a genetic mutation is the cause of your PD. If so I would tell your Movement specialist . Medicine is getting more personalized and you might have a mutation that has a corrective sequence. They can correct your brain cells possibly.

You may also like...

A potential case of remission of Parkinson’s disease

remission, such as a previously uncharacterized disease progression, an unusually positive response...

FDA Approves Focused Ultrasound Treatment for Parkinson’s Disease

https://www.fusfoundation.org/news/fda-approves-focused-ultrasound-treatment-for-parkinsons-disease...

Decreasing dopamine treatment levels In late stage Parkinson’s disease.

Bee venom for the treatment of Parkinson’s disease: How far is it possible? 2017

the treatment of Parkinson’s disease: How far is it possible? 2017...

Harnessing Probiotics to Deliver Parkinson’s Disease Treatment

a powerful mainstay treatment for Parkinson’s disease. Preclinical tests show that the new treatment